Venturi Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Venturi Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Sell	27,337 -13,023	-32%	-$176K	0.02%	431
2026 Q1	$559K	Buy	40,360 +25,660	+175%	+$357K	0.03%	323
2025 Q4	$206K	Buy	14,700 +2,703	+23%	+$37.9K	0.01%	552
2025 Q3	$168K	Buy	11,997 +1,840	+18%	+$26.5K	0.01%	557
2025 Q2	$153K	Buy	+10,157	New	+$145K	0.01%	529
2024 Q4	–	Sell	-3,755	Closed	-$59.7K	–	2027
2024 Q3	$59.7K	Buy	+3,755	New	+$60.4K	﹤0.01%	709
2023 Q2	–	Sell	-110	Closed	-$1.25K	–	1218
2023 Q1	$1.25K	Buy	+110	New	+$1.19K	﹤0.01%	1081

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Venturi Wealth Management's RDY Position: Q2 2026 in Review

Venturi Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 32% in Q2 2026, selling an estimated $176K and leaving 27,337 shares worth $396K. The position accounts for 0.02% of the portfolio, ranked #431.

Venturi Wealth Management first reported a position in RDY in Q1 2023 and has held it in 7 quarters since. The position peaked at $559K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Venturi Wealth Management held 27,337 shares of Dr. Reddy's Laboratories worth $396K as of Q2 2026.
Venturi Wealth Management sold 13,023 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $176K.
Dr. Reddy's Laboratories made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #431 holding.
Venturi Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 7 quarters since.
Venturi Wealth Management's Dr. Reddy's Laboratories position peaked at $559K in Q1 2026.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.